BGI Genomics Co (SZSE:300676) FCF Margin % : -22.54% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BGI Genomics Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-185 Mil. BGI Genomics Co's Revenue for the three months ended in Mar. 2024 was ¥821 Mil. Therefore, BGI Genomics Co's FCF Margin % for the quarter that ended in Mar. 2024 was -22.54%.

As of today, BGI Genomics Co's current FCF Yield % is -4.89%.

The historical rank and industry rank for BGI Genomics Co's FCF Margin % or its related term are showing as below:

SZSE:300676' s FCF Margin % Range Over the Past 10 Years
Min: -49.86 Med: -8.32 Max: 39.32
Current: -18.84

During the past 12 years, the highest FCF Margin % of BGI Genomics Co was 39.32%. The lowest was -49.86%. And the median was -8.32%.

SZSE:300676's FCF Margin % is ranked worse than
55.41% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.715 vs SZSE:300676: -18.84

BGI Genomics Co FCF Margin % Historical Data

The historical data trend for BGI Genomics Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co FCF Margin % Chart

BGI Genomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-14.36

39.32

30.93

-16.10

-19.03

BGI Genomics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-22.88	-26.51	-23.25	-5.30	-22.54

Competitive Comparison of BGI Genomics Co's FCF Margin %

For the Diagnostics & Research subindustry, BGI Genomics Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BGI Genomics Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BGI Genomics Co's FCF Margin % falls into.

BGI Genomics Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BGI Genomics Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-827.617	/	4349.637
	=	-19.03 %

BGI Genomics Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-185.087	/	821.25
	=	-22.54 %

BGI Genomics Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BGI Genomics Co (SZSE:300676) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083

Website

http://www.bgi.com

BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.

Executives

Wang Jian	Director
Liu Na	Executives
Sun Ying Jun	Director
Yin Ye	Directors, executives
Du Yu Tao	Directors, executives
Li Song Gang	Supervisors
Hu Yu Jie	Supervisors
Xu Qian	Secretary Dong
Li Zhi Ping	Executives
Chen Yi Qing	Executives
Li Wen Qi	Supervisors

BGI Genomics Co (SZSE:300676) Headlines

No Headlines